Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Breddin

Showing results (171-180 of 213) with videos related to

Pageof 22
Sort By:
Haemostasis|May 1, 1996
A recombinant hirudin (IK-HIR02) in healthy volunteers. I. Effects on coagulation parameters and bleeding timeJ F Schenk, E Glusa, P Radziwon, et al.
Seminars in Thrombosis and Hemostasis|January 1, 1991
Molecular and functional heterogeneity in dermatan sulfate preparationsJ Fareed, D Hoppensteadt, J M Walenga, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|November 18, 1998
A supersulfated low-molecular-weight heparin (IK-SSH) increases plasma levels of free and total tissue factor pathway inhibitor after intravenous and subcutaneous administration in humansB Kaiser, E Glusa, D A Hoppensteadt, et al.
Klinische Padiatrie|November 1, 1994
Univariate tolerance regions for fibrinogen, antithrombin III, protein C, protein S, plasminogen and alpha 2-antiplasmin in children using the new Automated Coagulation Laboratory (ACL) methodU Nowak-Göttl, M Funk, G Mosch, et al.
Klinische Padiatrie|November 1, 1991
15 parameters of coagulation and fibrinolysis in children with type I diabetes mellitus (onset period)M Koert, U Nowak-Göttl, W Kreuz, et al.
Seminars in Thrombosis and Hemostasis|January 1, 1991
Action of modified heparins on coagulation: in vitro and in vivo studiesA W Stemberger, A Riedl, S Haas, et al.
Roczniki Akademii Medycznej W Bialymstoku (1995)|January 1, 1996
The role of monocytes in the platelet release of von Willebrand factorJ Giedrojć, K Krupiński, P Radziwon, et al.
Blut|December 15, 1978
[Primary shape change of platelets in vitro (author's transl)]E Bamberg, O Bauer, W Herrmann, et al.
Atherosclerosis|June 25, 1999
Spontaneous platelet aggregation as a predictive risk factor for vascular occlusions in healthy volunteers? Results of the HAPARG Study. Haemostatic parameters as risk factors in healthy volunteersH K Breddin, R Lippold, M Bittner, et al.
Folia Haematologica (Leipzig, Germany : 1928)|January 1, 1988
Inhibition of platelet activation by 2-mercaptopropionylglycin in vitro and in vivoW Loesche, K Breddin, G P Pescarmona, et al.
Pageof 22

Showing results (171-180 of 213) with videos related to

Sort By:
Pageof 22
Haemostasis|May 1, 1996
A recombinant hirudin (IK-HIR02) in healthy volunteers. I. Effects on coagulation parameters and bleeding timeJ F Schenk, E Glusa, P Radziwon, et al.
Seminars in Thrombosis and Hemostasis|January 1, 1991
Molecular and functional heterogeneity in dermatan sulfate preparationsJ Fareed, D Hoppensteadt, J M Walenga, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|November 18, 1998
A supersulfated low-molecular-weight heparin (IK-SSH) increases plasma levels of free and total tissue factor pathway inhibitor after intravenous and subcutaneous administration in humansB Kaiser, E Glusa, D A Hoppensteadt, et al.
Klinische Padiatrie|November 1, 1994
Univariate tolerance regions for fibrinogen, antithrombin III, protein C, protein S, plasminogen and alpha 2-antiplasmin in children using the new Automated Coagulation Laboratory (ACL) methodU Nowak-Göttl, M Funk, G Mosch, et al.
Klinische Padiatrie|November 1, 1991
15 parameters of coagulation and fibrinolysis in children with type I diabetes mellitus (onset period)M Koert, U Nowak-Göttl, W Kreuz, et al.
Seminars in Thrombosis and Hemostasis|January 1, 1991
Action of modified heparins on coagulation: in vitro and in vivo studiesA W Stemberger, A Riedl, S Haas, et al.
Roczniki Akademii Medycznej W Bialymstoku (1995)|January 1, 1996
The role of monocytes in the platelet release of von Willebrand factorJ Giedrojć, K Krupiński, P Radziwon, et al.
Blut|December 15, 1978
[Primary shape change of platelets in vitro (author's transl)]E Bamberg, O Bauer, W Herrmann, et al.
Atherosclerosis|June 25, 1999
Spontaneous platelet aggregation as a predictive risk factor for vascular occlusions in healthy volunteers? Results of the HAPARG Study. Haemostatic parameters as risk factors in healthy volunteersH K Breddin, R Lippold, M Bittner, et al.
Folia Haematologica (Leipzig, Germany : 1928)|January 1, 1988
Inhibition of platelet activation by 2-mercaptopropionylglycin in vitro and in vivoW Loesche, K Breddin, G P Pescarmona, et al.
Pageof 22